You have 9 free searches left this month | for more free features.

Condition

Pulmonary Arterial Hypertension (2)

Drug Drug Interaction (1)

Dyskinesia, Medication-Induced (1)

L-Dopa Causing Adverse Effects in Therapeutic Use (1)

Neuropathic Pain (1)

Parkinson Disease (1)

Overall Status

Recruiting (3)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2/phase 3 (2)

phase 2 (1)

Sponsor

VistaGen Therapeutics, Inc. (3)

Aerovate Therapeutics (2)

Collaborator

Cato Research (1)

National Institute on Drug Abuse (NIDA) (1)

Parexel (1)

Intervention

av-101 (5)

placebo (3)

probenecid (1)

Study Documents

Intervention Type

drug (5)

Funder Type

Industry (5)

Study Type

Interventional (5)

av-101

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)

Recruiting

Pulmonary Arterial Hypertension

AV-101

Indianapolis, Indiana

Indiana University Health

Dec 6, 2022

Drug Drug Interaction Trial in Glendale (AV-101, Probenecid)

Recruiting

Drug Drug Interaction

AV-101
Probenecid

Glendale, California

Parexel Early Phase Clinical Unit

Mar 3, 2022

Pulmonary Arterial Hypertension Trial in Worldwide (AV-101, Placebo)

Recruiting

Pulmonary Arterial Hypertension

AV-101
Placebo

Phoenix, Arizona
+15 more

Aug 12, 2022

Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use Trial (AV-101, Placebo)

Not yet recruiting

Parkinson Disease
+2 more

AV-101
Placebo

(no location specified)

May 25, 2021

Neuropathic Pain Trial in San Diego (AV-101, Placebo)

Completed

Neuropathic Pain

AV-101
Placebo

San Diego, California

UCSD Medical Center

Dec 18, 2012